With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

Mumbai-based Kilitch Drugs Ltd plans to enter biosimilars and oral solids, including diabetic and weight-loss tablets, and is ...

India's obesity crisis is intensifying, with big pharma companies like Eli Lilly and Novo Nordisk competing to introduce ...

Obesity remains a significant public health challenge in the UK, with over 26% of adults classified as obese and an additional 38% considered overweight. This epidemic not only impacts individual ...

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

GlobalData’s latest report, “Type 1 Diabetes: Seven-Market Drug Forecast and ... After one year, the tirzepatide group experienced an average weight loss of 21.4% and a 0.67 percentage point ...

Less than five years on from when ... to license it's novel weight-loss and diabetes drug UBT251 to the rest of the world. United will keep the rights to market the medication in China, Hong ...

Weight loss “wonder drug” Wegovy will cost Irish users around ... As a result, patients will have to pay up to €2,640 a year to access the Wegovy. That is less than the cost of Mounjaro ...